×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Vouchers
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Moneycontrol mutual fund summit 2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Budget 2026
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
PF
Forum
Videos
you are here:
Home
News
Sparc
Sparc
SPARC shares crash 19% after Psoriasis drug fails to deliver in trials
SPARC up 12% ahead of update on clinical programs, R&D pipeline this week
Sun Pharma Advanced slips 5% on halting Parkinson's drug trial
Sun Pharma inks licensing pact with SPARC to commercialise medication in US market
Trade Spotlight | What should you do with Shoppers Stop, Sharda Cropchem, SPARC, Hitachi Energy and Bajaj Auto?
SPARC inks licensing pact with Visiox Pharma for ophthalmic products
Dilip Shanghvi resigns as MD of SPARC: Here's what you need to know about him
Union Education Ministry releases Rs 80 crore to IIT Kharagpur for second phase of SPARC
'Nifty to head towards 12,700 levels, but money will likely be made in mid & smallcaps'
Abraxis Bioscience LLC dismisses patent infringement complaint against SPARC
Market Headstart: Nifty50 seen opening higher; 3 stocks which could give 5-10% return
Market Headstart | Nifty likely to open flat; 3 stocks that could give 7-12% return
Podcast | Stock picks of the day: Nifty could remain in upward consolidation mode
SPARC, Schrödinger announce research collaboration for novel CNS therapeutics
SPARC jumps 8% on successful pivotal bioequivalence study for cancer drug
Market Now: Jewellery stocks shine - PC Jeweller, Titan up 3-4%; ICICI Bank top gainer
SPARC jumps 4% on topline results of PIF and low dose PK study for dry powder inhaler
Stocks in the news: Bajaj Auto, Laurus Labs, M&M, Bhushan Steel, SPARC, Deccan Cements
SPARC spikes 7% on USFDA's complete response letter for Xelpros
Sensex, Nifty continue to fall; Midcap breaks 200-DMA, SPARC up
Buy Tata Steel, sell Infosys: Mitesh Thacker
Cadila Healthcare may test Rs 393: Rajat Bose
Buy SPARC, says Mitesh Thacker
SPARC Q4 net loss widens to Rs. 9.6 crore
Hold SPARC, says Sharmila Joshi
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio